ORION THERAPEUTICS INC.
KNOXVILLE, TN · Founded 2022 · CIK 0001958173 · Biotech · Private
Customizable lipid nanoparticles for targeted RNA therapeutic delivery to specific tissues
- Grants
- $1.2M
- 1 award
- Sector median: 1
- Raised
- $145K
- 2 Form D · Sep 2024
- 24 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $60,000 | |
| Private capital raised | Form D · SEC | $85,000 | |
| Federal grant | National Science Foundation · Phase II · STTR Phase II: Multifunctional Lipid Nanoparticle Delivery System for Targeted Delivery of Vascular RNA Therapeutics | $1,249,673 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2648 | ViroMissile, Inc. | — | $150K |
| 2649 | Integrated Micro-Chromatography Systems, Inc. | — | $150K |
| 2650 | SIDERO BIOSCIENCE, LLC | — | $145K |
| 2651 | ORION THERAPEUTICS INC. | — | $145K |
| 2652 | Finch Therapeutics, Inc. | — | $4.5M |
| 2653 | TARTAN LLC | — | $130K |
| 2654 | NEUIMMUNE, INC. | — | $125K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard FisherDirector · Executive Officer
- Michael McCamanDirector · Executive Officer
- Deidra MountainDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.